Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients
1999

Using PET Scans to Evaluate Nerve Issues in Breast Cancer Patients

Sample size: 19 publication Evidence: moderate

Author Information

Author(s): Ahmad A, Barrington S, Maisey M, Rubens R D

Primary Institution: Clinical Oncology Unit, Guy's Hospital

Hypothesis

Can positron emission tomography (PET) effectively evaluate brachial plexopathy in breast cancer patients?

Conclusion

The study suggests that 18FDG-PET scanning is a useful tool for evaluating patients with suspected metastatic plexopathy.

Supporting Evidence

  • 14 out of 19 patients had abnormal uptake of 18FDG in the symptomatic plexus.
  • CT scans in 9 patients with positive PET studies showed 3 with clear brachial plexus involvement.
  • Two patients with normal PET studies had one with complete symptom resolution and another with cervical disc herniation.

Takeaway

Doctors used a special scan called PET to check if breast cancer patients had nerve problems, and it helped them find out if the issues were caused by cancer or treatment.

Methodology

The study evaluated 19 breast cancer patients with symptoms of brachial plexopathy using 18FDG-PET and CT scans.

Participant Demographics

Breast cancer patients with symptoms/signs referable to the brachial plexus.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690074

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication